Oppenheimer raised the firm’s price target on Transcat to $160 from $125 and keeps an Outperform rating on the shares. The firm says the company’s Q4 is another solid showcase of management execution and its business momentum. Oppenheimer expects larger acquisitions, ongoing automation and process improvements, and introduction of Transcat Single Source Solution to continue to drive top-line growth and margin expansion. The firm remains confident in its thesis of sustained revenue growth and margin expansion.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRNS:
